Seeing Is Believing
Currently out of the existing stock ratings of Howard Liang, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst Howard Liang works with a stock forecast success ratio of 100% fulfilled within 1099 days on average. Previously, Howard Liang worked at LEERINK.
Howard Liang’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 22-Apr-2015.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 10/2/2013. The price target of $128 was fulfilled within 393 days with a profit of $39.47 (44.58%) receiving and performance score of 1.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
284
$10.99 (4.03%)
314
9 days ago
8/9 (88.89%)
$19.93 (7.55%)
96
Buy
320
$46.99 (17.21%)
320
14 days ago
24/25 (96%)
$52.72 (19.72%)
714
Buy
350
$76.99 (28.20%)
258
2 months 18 days ago
1/2 (50%)
$57.44 (19.63%)
325
Buy
329
$55.99 (20.51%)
300
2 months 19 days ago
6/8 (75%)
$35.42 (12.06%)
68
Buy
350
$76.99 (28.20%)
310
2 months 25 days ago
29/30 (96.67%)
$27.96 (8.68%)
508
What Year was the first public recommendation made by Howard Liang?